2nd Quarter - Termination
TAP PHARMACEUTICAL PRODUCTS for TAP PHARMACEUTICAL PRODUCTS
Client
Income
—
Expenses
$360,000
Expense method
A: Lobbying Disclosure Act definitions
Terminated
Jun 30, 2008
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Anti-counterfeiting. Medicare and Medicaid payment policies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURA ELIZABETH CLINE | — |
| DEBORAH LYNN WALTER | — |
Affiliated organisations
| Organisation | Location |
|---|---|
| ABBOTT LABORATORIES | Washington, DC, US |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.